{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:07:37Z","timestamp":1770512857294,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Lehigh County Drug and Alcohol Authority and the Pennsylvania Department of Drug & Alcohol Programs","award":["23-1689692"],"award-info":[{"award-number":["23-1689692"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13181-020-00813-4","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:02:47Z","timestamp":1604505767000},"page":"176-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-8695","authenticated-orcid":false,"given":"Gillian A.","family":"Beauchamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lexis T.","family":"Laubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha B.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Yazdanyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Lauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Boateng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Shaak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"813_CR1","unstructured":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. 2018. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHNationalFindingsReport2018\/NSDUHNationalFindingsReport2018.pdf. Accessed Aug 15, 2020."},{"issue":"1","key":"813_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell J, Strang J. Medication treatment of opioid Use disorder. Biol Psychiatry. 2020;87(1):82\u20138.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"813_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S2215-0366(19)30213-5","volume":"6","author":"J Knox","year":"2019","unstructured":"Knox J, Hasin D, Larson F, Kranzler H. Prevention, screening, and treatment for heavy drinking and alcohol use disorder. Lancet Psychiatry. 2019;6(12):1054\u201367.","journal-title":"Lancet Psychiatry"},{"key":"813_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"V Dole","year":"1965","unstructured":"Dole V, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA. 1965;193:646\u201350.","journal-title":"JAMA."},{"issue":"1","key":"813_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1360-0443.2011.03577.x","volume":"107","author":"L Amass","year":"2012","unstructured":"Amass L, Pukeleviciene V, Subata E, Almeida AR, Pieri MC, D'Egidio P, et al. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine\/naloxone induction in heroin-dependent individuals. Addiction. 2012;107(1):142\u201351.","journal-title":"Addiction."},{"issue":"3","key":"813_CR6","first-page":"CD002209","volume":"2009","author":"R Mattick","year":"2009","unstructured":"Mattick R, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):CD002209.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"813_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13181-019-00728-9","volume":"15","author":"R Marino","year":"2019","unstructured":"Marino R, Perrone J, Nelson L, et al. ACMT position statement: remove the waiver requirement for prescribing buprenorphine for opioid use disorder. J Med Toxicol. 2019;15(4):307\u20139.","journal-title":"J Med Toxicol"},{"key":"813_CR8","unstructured":"(SAMHSA) SA and MHSAC. The DAWN Report - Highlights of the 2010 Drug abuse warning network findings on drug-related emergency department visits. Drug Abuse Warning Network. 2010. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DAWN096\/DAWN096\/SR096EDHighlights2010.htm. Accessed Aug 15, 2020."},{"key":"813_CR9","unstructured":"World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009. Available at: https:\/\/www.who.int\/substance_abuse\/publications\/Opioid_dependence_guidelines.pdf. Accessed Aug 15, 2020."},{"key":"813_CR10","unstructured":"Rinaldo SG, Rinaldo DW. Advancing access to addiction medications : implications for opioid addiction treatment. Am Soc Addict Med 2013. Available at: https:\/\/www.asam.org\/docs\/default-source\/advocacy\/aaam_implications-for-opioid-addiction-treatment_final.pdf?sfvrsn=cee262c2_25. Accessed Aug 15, 2020."},{"key":"813_CR11","unstructured":"Alexander G, Frattaroli S, Gielen A. The prescription opioid epidemic: an evidence- based approach. Johns Hopkins Bloomberg School of Public Health. 2015. Available at: https:\/\/www.jhsph.edu\/research\/centers-and-institutes\/center-for-drug-safety-and- effectiveness\/research\/prescription-opioids\/JHSPH_OPIOID_EPIDEMIC_REPORT.pdf. Accessed Aug 15, 2020."},{"issue":"8","key":"813_CR12","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"C Jones","year":"2015","unstructured":"Jones C, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55\u201363.","journal-title":"Am J Public Health"},{"issue":"8","key":"813_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1176\/appi.ajp.158.8.1200","volume":"158","author":"D Fiellin","year":"2001","unstructured":"Fiellin D, Rosenheck R, Kosten T. Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry. 2001;158(8):1200\u20134.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"813_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","volume":"39","author":"H Pinto","year":"2010","unstructured":"Pinto H, Maskrey V, Swift L, Rumball D, Wagle A, Holland R. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abus Treat. 2010;39(4):340\u201352.","journal-title":"J Subst Abus Treat"},{"key":"813_CR15","unstructured":"Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration 2016. Available at: https:\/\/www.samhsa.gov\/data\/report\/key-substance-use-and-mental-health-indicators-united-states-results-2015-national-survey. Accessed Aug 15, 2020."},{"issue":"1","key":"813_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/cem.2017.390","volume":"20","author":"L Lacroix","year":"2018","unstructured":"Lacroix L, Thurgur L, Orkin AM, Perry JSI. Emergency physicians\u2019 attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian Emergency Departments. CJEM. 2018;20(1):46\u201352.","journal-title":"CJEM."},{"issue":"1","key":"813_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.annemergmed.2019.08.420","volume":"75","author":"F Edwards","year":"2020","unstructured":"Edwards F, Wicelinski R, Gallagher N, Mckinzie A, White R, Domingos A. Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program. Ann Emerg Med. 2020;75(1):49\u201356.","journal-title":"Ann Emerg Med"},{"issue":"16","key":"813_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D\u2019Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor P, Pantalon M, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636\u201344.","journal-title":"JAMA."},{"issue":"2","key":"813_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ajem.2019.158373","volume":"38","author":"K Kaucher","year":"2020","unstructured":"Kaucher K, Caruso E, Sungar G, Gawenus L, Hurlbut K, Sanchez DC, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2020;38(2):300\u20134.","journal-title":"Am J Emerg Med"},{"issue":"11","key":"813_CR20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/add.13900","volume":"112","author":"S Busch","year":"2017","unstructured":"Busch S, Fiellin D, Chawarski M, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002\u201310.","journal-title":"Addiction."},{"key":"813_CR21","unstructured":"Drug Enforcement Administration D of J. Implementation of the provision of the comprehensive addiction and recovery act of 2016 relating to the dispensing of narcotic drugs for opioid use disorder. Final Rule. 2018. Available at: https:\/\/www.federalregister.gov\/documents\/2018\/01\/23\/2018-01173\/implementation-of-the-provision-of-the-comprehensive-addiction-and-recovery-act-of-2016-relating-to. Accessed Aug 15, 2020."},{"issue":"2","key":"813_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"P Harris","year":"2009","unstructured":"Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"813_CR23","unstructured":"Chou R, Korthuis P, Weimer M, et al. Medication-assisted treatment models of care for opioid use disorder in primary care settings. In: Agency for Healthcare Research and Quality; 2016. Technical Briefs, No. 28. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK402352\/. Accessed Aug 15, 2020."},{"issue":"1","key":"813_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.annemergmed.2017.10.002","volume":"72","author":"J Love","year":"2018","unstructured":"Love J, Perrone J, Nelson L. Should buprenorphine be administered to patients with opioid withdrawal in the emergency department? Ann Emerg Med. 2018;72(1):26\u20138.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"813_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","volume":"73","author":"A Herring","year":"2019","unstructured":"Herring A, Perrone J, Nelson L. Managing opioid withdrawal in the emergency department with buprenorphine. Ann Emerg Med. 2019;73(5):481\u20137.","journal-title":"Ann Emerg Med"},{"issue":"26","key":"813_CR26","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMp1811988","volume":"379","author":"G D\u2019Onofrio","year":"2018","unstructured":"D\u2019Onofrio G, McCormack R, Hawkk K. Emergency departments - a 24\/7\/365 option for combating the opioid crisis. N Engl J Med. 2018;379(26):2487\u201390.","journal-title":"N Engl J Med"},{"issue":"3","key":"813_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s13181-019-00712-3","volume":"15","author":"P Wax","year":"2019","unstructured":"Wax P, Stolbach A, Schwarz E, Warrisck B, Wiegand T, Nelson L. ACMT position statement: buprenorphine Administration in the Emergency Department. J Med Toxicol. 2019;15(3):215\u20136.","journal-title":"J Med Toxicol"},{"issue":"1","key":"813_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajem.2018.10.013","volume":"37","author":"D Cisewski","year":"2019","unstructured":"Cisewski D, Santos C, Koyfman A, Long B. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. Am J Emerg Med. 2019;37(1):143\u201350.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"813_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13181-019-00752-9","volume":"16","author":"J Carpenter","year":"2020","unstructured":"Carpenter J, Murray B, Mazer-Amirshahi M, et al. Leadership roles in opioid stewardship and the treatment of patients with opioid use disorder among medical toxicologists. J Med Toxicol. 2020;16(2):204\u201311.","journal-title":"J Med Toxicol"},{"issue":"1","key":"813_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s13181-015-0518-4","volume":"12","author":"TJ Wiegand","year":"2016","unstructured":"Wiegand TJ. The new kid on the block--incorporating buprenorphine into a medical toxicology practice. J Med Toxicol. 2016;12(1):64\u201370.","journal-title":"J Med Toxicol"},{"issue":"3","key":"813_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10550887.2012.694598","volume":"31","author":"G Bart","year":"2012","unstructured":"Bart G. Maintenance medication for opiate addiction: the Foundation of Recovery. J Addict Dis. 2012;31(3):207\u201325.","journal-title":"J Addict Dis"},{"issue":"5","key":"813_CR32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12788\/jhm.2736","volume":"12","author":"H Englander","year":"2017","unstructured":"Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339\u201342.","journal-title":"J Hosp Med"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-020-00813-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T21:06:46Z","timestamp":1617311206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-020-00813-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s13181-020-00813-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}